kidney trasplant research hub

IMLIFIDASE IN LIVING DONOR RENAL TRANSPLANTATION: HIGHLY SENSITIZED RECIPIENTS (LIVEDES STUDY)

This study looks at a new treatment called imlifidase for people who need a kidney transplant but have strong antibodies that make it hard to find a match. It aims to see if imlifidase can help these patients receive a life-changing kidney from a living donor.